Anas Younes
Intercept Pharmaceuticals (United States)(US)New York Chiropractic College(US)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Viral-associated cancers and disorders, CAR-T cell therapy research, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer(2016)1,942 cited
- → Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma(2012)1,502 cited
- → Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas(2010)1,341 cited
- → Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial(2016)915 cited
- → Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review(2008)767 cited
- → Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma(2017)747 cited